FDA’s Patient-Focused Drug Development Meetings Inspire Imitators

19 May 2014

FDA likes the idea of advocacy groups convening their own meetings, but some stakeholders say the conversations need more depth.

Patient groups may end up supplementing FDA’s patient-focused drug development efforts by holding their own information-gathering meetings.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

Already a subscriber?